Bioyitech Awarded Scientific and Technological Achievement Evaluation Certificate, Supporting the National Probiotic Strategic Layout
On November 3, 2024, the scientific and technological achievement "Preparation and Application of Lactobacillus Metabolizing Tryptophan and Galactooligosaccharides and Their Synbiotics," jointly completed by Dalian University of Technology and Bioyitech, successfully passed the professional review of the Zhongkehechuang (Beijing) Technology Achievement Evaluation Center. It was awarded the Scientific and Technological Achievement Evaluation Certificate, with certificate number 202421ZK9789. The evaluation of this achievement is not only a high recognition of Bioyitech's scientific research strength in the field of probiotics but also a crucial step forward for China in its national probiotic strategic layout.
This award-winning scientific and technological achievement focuses on the core needs of China's infant formula food industry, successfully developing the plant Lactobacillus DPUL - S164 and Lactobacillus reuteri DPUL - M94 with independent intellectual property rights, as well as the corresponding synbiotic preparation technology. During the research process, the expert team delved into the impact and mechanism of action of Lactobacillus metabolites on intestinal barrier function, discovering that they can enhance immune function, improve intestinal microbial diversity, and effectively alleviate inflammation and intestinal barrier damage caused by complementary food feeding. These achievements not only solve the scientific problem of unclear chemical properties and functional characteristics of synbiotic product efficacy components but also provide new options for Probiotic Strains and preparations for China's infant formula food.
From the perspective of the national probiotic strategic layout, this achievement is of great significance. On the one hand, it breaks the long-term monopoly of foreign technology and products in the field of probiotics and preparations in China's infant formula food industry, making China no longer subject to others in this key core technology, effectively ensuring the autonomy and safety of the national food safety strategy. On the other hand, it injects strong momentum into the innovative development of China's probiotic industry, helping to promote the upgrading and transformation of related domestic industries, enhance China's competitiveness in the global probiotic market, and promote the healthy, orderly, and sustainable development of the probiotic industry.
Currently, this scientific and technological achievement has been researched in pilot production of products（Bifidobacterium animalis subsp. Lactis F1-7 , Lactiplantibacillus plantarum F3-2） in units such as Bioyitech. Practice has proven its high technical feasibility and stable and reliable product quality. This lays a solid foundation for subsequent industrialization promotion, is expected to further improve the economic benefits of China's probiotic industry, create good social benefits, and contribute scientific and technological strength to the realization of the people's "better life" vision.
Bioyitech will continue to uphold the concept of scientific and technological innovation, give full play to its advantages in the field of probiotic research and development, continuously deepen cooperation with major scientific research institutions and enterprises, and is committed to developing more probiotic products and technologies with independent intellectual property rights, contributing continuously to the vigorous development of China's probiotic industry and the perfect implementation of the national probiotic strategic layout.